loadpatents
Patent applications and USPTO patent grants for Luye Pharma AG.The latest application filed is for "transdermal therapeutic system for administering an active substance".
Patent | Date |
---|---|
Transdermal therapeutic system with an overtape comprising two adhesive layers Grant 11,013,697 - Schurad , et al. May 25, 2 | 2021-05-25 |
Transdermal Therapeutic System for Administering an Active Substance App 20200289426 - LANGER; Britta ;   et al. | 2020-09-17 |
Lattice loss reduction Grant 10,758,495 - Grader , et al. Sep | 2020-09-01 |
Device for the manufacture of pharmaceutical patches Grant 10,759,076 - Grader , et al. Sep | 2020-09-01 |
Transdermal therapeutic system for administering an active substance Grant 10,660,863 - Langer , et al. | 2020-05-26 |
Transdermal therapeutic system for administering rivastigmine or derivatives thereof Grant 10,076,502 - Prinz , et al. September 18, 2 | 2018-09-18 |
Transdermal Therapeutic System With An Overtape Comprising Two Adhesive Layers App 20180028465 - SCHURAD; Bjorn ;   et al. | 2018-02-01 |
Implant cannula having an implant and a method for securing implants in an injection cannula Grant 9,616,212 - Spilgies April 11, 2 | 2017-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.